Danaparoid

Traleusin 750 U Anti-Xa/0,6 ML Solucion Inyectable y Para Perfusion

1.250 anti-Xa UI/ml solucion inyectable y para perfusionSpainMarketedAuthorised 9 Dec 2021

In other countries

The same active substances on other registers, the same brand first.

TraleusinItaly · Soluzione iniettabile · Viatris Italia S.R.L.Same brand
Danaparoid natrium Viatris, 750 anti-Xa eenheden/0,6 ml, oplossing voor injectie/infusieNetherlands · Oplossing voor injectie of infusie · Viatris LimitedSame form
Danaparoid natrium Viatris, 750 anti-Xa-eenheden, oplossing voor injectieNetherlands · Oplossing voor injectie · Viatris LimitedSame form
Orgaran, 750 anti-Xa eenheden, oplossing voor injectieNetherlands · Oplossing voor injectie · Viatris Healthcare LimitedSame form
AnyNew Zealand · Inj 750 u in 0.6 ml ampouleSame form
OrgaranUnited States · 750 UNITS/0.6ML · injectable · Aspen Global INCSame form

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Danaparoid

Traleusin 750 U Anti-Xa/0,6 ML Solucion Inyectable y Para Perfusion

1.250 anti-Xa UI/ml solucion inyectable y para perfusionSpainMarketedAuthorised 9 Dec 2021

Product informationAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

OrgaranCanada · 750 UNIT / 0.6 ML · Solution · Aspen Pharmacare Canada INC.

Packs

Pack	Code	Status
TRALEUSIN 750 U ANTI-XA/0,6 ML SOLUCION INYECTABLE Y PARA PERFUSION, 10 ampollas	732410

Documents

The official texts, at the regulator.

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Agencia Española de Medicamentos y Productos Sanitarios

Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.

Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required · Added 12 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Danaparoid
Strength: 1.250 anti-Xa UI/ml
Dosage form: solucion inyectable y para perfusion
Route: vía intravenosa, vía subcutánea
Register: Spain (AEMPS)
Status: Marketed
Status in the register: Autorizado, comercializado
Authorised: 9 Dec 2021
Registration: 86436
Marketing authorisation holder: Viatris Limited
Procedure: National, MRP or DCP
Supply: Uso Hospitalario